- Biocon inks pact with Amylin to develop diabetes therapy - Business Standard
- Biocon Limited Announces Results for the Half-Year Ended September 30, 2009 - Business Wire India (press release)
- Biocon, Amylin Pharma tie up to develop new diabetes drug - Moneycontrol.com
- Max India posts a net profit of Rs 20.2 cr - Business Standard
- GVK Biosciences organises workshop on clinical trials - SamayLive
Biocon triples Q2 net profit - Business Standard
Deccan HeraldBiocon triples Q2 net profitBusiness Standard... attributed the growth to the performance of its German subsidiary AxiCorp, its R&D unit Syngene, clinical research outsourcing arm Clinigene, ...Biocon Q2 net jumps three-fold at Rs 74 crmydigitalfc.comBiocon Limited Announces Results for the Half-Year Ended September 30, 2009Business Wire India (press release)Biocon's total income stands at Rs 592 cr, net profit Rs 74 cr in Q2pharmabiz.comDeccan Herald -Daijiworld.com -Livemintall 116 news articles »
